Jeffrey Leipzig
Allergy & Immunology · Oxford, OHNPI 1750325718
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,293 and has fallen 75.9% since, to $311 in 2023.
Across 198 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$994
- GSK$660
- Regeneron Healthcare Solutions, Inc.$535
- Sanofi$383
- Johnson & Johnson$317
- Optinose US, Inc.$254
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,436100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $994 |
| GSK | 34 | $660 |
| Regeneron Healthcare Solutions, Inc. | 34 | $535 |
| Sanofi | 23 | $383 |
| Johnson & Johnson | 3 | $317 |
| Optinose US, Inc. | 13 | $254 |
| Alk-abello, Inc | 6 | $251 |
| Pfizer | 9 | $210 |
| Covis Pharma GmbH | 8 | $132 |
| Janssen Scientific Affairs, LLC | 1 | $130 |
| Amarin Pharma, Inc. | 1 | $91 |
| Bristol Myers Squibb | 1 | $83 |
| Novartis | 6 | $81 |
| Grifols USA, LLC | 3 | $50 |
| Biocryst US Sales Co., LLC | 3 | $46 |
| Boehringer Ingelheim | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| CSL Behring | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Kaleo, Inc. | 2 | $29 |
| Merck | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,436 in reported general payments places this provider in the 60th percentile of 128 allergy & immunology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 32 | $982 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $934 |
| Montelukast Sodium | 45 | $402 |
| Fluticasone Propionate | 19 | $163 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Oxford
- Justin GreiweCincinnati$1M
- Jonathan BernsteinCincinnati$810K
- Adam UpdegraffToledo$379K
- Syed RehmanToledo$374K
- Gordon MyersCincinnati$346K
- Nancy Wasserbauer KingstonRocky River$256K
- David LangCleveland$251K
- James FernandezCleveland$179K
- Donald McNeilColumbus$136K
- Amber PattersonFindlay$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.